Sangamo BioSciences Inc.
Q1 2012 Earnings Call
May 2, 2012; 05:00pm ET
Edward Lanphier - President & Chief Executive Office
Ward Wolffe - Executive Vice President & Chief Financial Officer
Geoff Nichol - Executive Vice President of Research & Development
Philip Gregory - Vice President of Research & Scientifics, Chief Scientific Officer
Dale Ando - Vice President of Development & Chief Medical Officer
Elizabeth Wolffe - Senior Director of Corporate Communications
Charles Duncan - JMP Securities
Liana Moussatos - Wedbush Securities
Joseph Schwartz - Leerink Swann
Good afternoon and welcome to the Sangamo BioSciences teleconference to discuss first quarter 2012 financial results. This conference call is being recorded. I will now pass you over to the coordinator for this event, Dr. Elizabeth Wolffe, Senior Director of Corporate Communications.
Thank you Mammy. Good afternoon and thank you for joining Sangamo's management team on our conference call to discuss the company's first quarter 2012 financial results.
Also present during this call are several members of Sangamo Senior Management, including Edward Lanphier, President and Chief Executive Office; Ward Wolffe, Executive Vice President and Chief Financial Officer; Geoff Nichol, Executive Vice President of Research and Development; Philip Gregory, Vice President of Research and Scientifics, the Chief Scientific Officer; and Dale Ando, Vice President of Development and Chief Medical Officer.
Following this introduction, Edward will highlight recent activities and the significant events from the past quarter. Ward will then briefly review the first quarter financial results, as well as our financial guidance for 2012. Geoff will provide an update on our ZFP therapeutic programs, and finally Edward will update you on our goals for the rest of 2012. Following that we will open up the call for questions.